Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$18.6M
15M shares
52-week range
$0.81 – $16.59
2% from low
Exchange
NASDAQ
CS
Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.
www.dogness.comNo one on the platform currently holds DOGZ.
No tracked institution reports a position in DOGZ as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-11-07 | 1-for-20reverse |
No one on the platform has traded DOGZ yet.
Beat consensus in 1 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-10-12 | $3.20 | $-0.40 | -112.5% |
| 2023-04-06 | $2.60 | $-0.28 | -110.8% |
| 2022-09-30 | $0.10 | $0.19 | +92.5% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DOGZDogness (International) Corporation | $1.20 | -6.35% | $17M | — |
| AIIORobo.ai Inc. | $2.92 | -1.52% | $58M | — |
| CLARClarus Corporation | $3.73 | +1.49% | $144M | — |
| ESCAEscalade, Incorporated | $20.79 | +0.65% | $286M | — |
| FNKOFunko, Inc. | $6.00 | +1.44% | $335M | — |
| GDHGGolden Heaven Group Holdings Ltd. | $1.37 | +0.74% | $3M | — |
| JAKKJAKKS Pacific, Inc. | $25.42 | +1.03% | $291M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$IZM rockets in 10 minutes Lfg back to .40 $BANL $XHLD $dogz
View on StockTwits ↗$DOGZ A large clown show on here that doesn't seem to know what board they are on LOL
View on StockTwits ↗🔥 We're still smashing levels and spotting bangers today! Love seeing the team stay patient, stick to the plan, and continue finding quality opportunities. The momentum is alive—let's keep stacking disciplined trades. LFG! ⚔️📈 $XHLD - ALL levels smashed here 🔥🎯 $OFAL $BQ $DOGZ $CHOW
View on StockTwits ↗$HAO $OFAL $BQ $DOGZ $HYFM Huge upside! 🔥 TEENY FLOAT! Insane borrow 🚀🚀🚀
View on StockTwits ↗$HAO Volume coming into HAO. You were told..... $OFAL $BQ $DOGZ
View on StockTwits ↗$ONCY – FDA Fast Track + Strong Early Data Oncolytics Biotech just landed FDA Fast Track Designation for pelareorep in anal cancer — its second Fast Track indication alongside pancreatic cancer. Why it matters: ✅ Data: GOBLET Cohort 1 (pancreatic) posted a 62% objective response rate and 45% one-year survival ✅ Data: REO 022 (colorectal) showed 27-month median OS vs. 11.2 months on standard treatment ✅ Partnerships: Roche, Pfizer, Merck Serono, Incyte, and Adlai Nortye all collaborating on combo studies Likes to bottom out between .75-.80 level. Patent protection now extends to 2044, and leadership just relocated HQ to San Diego with new COO and board additions. Next catalyst is the registration-focused study design in KRAS-mutant, MSS colorectal cancer. Investors are watching trial design details and regulatory next steps over coming quarters. Communicated Disclaimer – https://stockresearchtoday.com/oncy/ NFA. DYOR. $OFAL $RMCF $BIVI $DOGZ
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.